Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Open Biology|March 17, 2026
A CDCA2-MYC positive feedback loop controls cancer cells survivalKonstantinos Stamatiou, Lorena Ligammari, Malki Bothota, et al.
Anticancer Research|November 2, 2010
Inhibition of Myc effectively targets KRAS mutation-positive lung cancer expressing high levels of MycTakuya Fukazawa, Yutaka Maeda, Junji Matsuoka, et al.
Neoplasia (New York, N.Y.)|December 2, 2011
Modeling pharmacological inhibition of mast cell degranulation as a therapy for insulinomaLaura Soucek, Joseph J Buggy, Roderik Kortlever, et al.
Genes & Development|March 12, 2013
Inhibition of Myc family proteins eradicates KRas-driven lung cancer in miceLaura Soucek, Jonathan R Whitfield, Nicole M Sodir, et al.
Oncotarget|April 23, 2016
Growth suppression by MYC inhibition in small cell lung cancer cells with TP53 and RB1 inactivationFrancesco Paolo Fiorentino, Elvan Tokgün, Sònia Solé-Sánchez, et al.
International Journal of Cancer|September 20, 2018
Inhibition of MYC attenuates tumor cell self-renewal and promotes senescence in SMARCB1-deficient Group 2 atypical teratoid rhabdoid tumors to suppress tumor growth in vivoIrina Alimova, Angela Pierce, Etienne Danis, et al.
Oncotarget|May 4, 2018
BET inhibition is an effective approach against KRAS-driven PDAC and NSCLCToni Jauset, Daniel Massó-Vallés, Sandra Martínez-Martín, et al.
Blood|November 10, 2011
Role of c-MYC in alternative activation of human macrophages and tumor-associated macrophage biologyOscar M Pello, Maria De Pizzol, Massimiliano Mirolo, et al.
Cancers|February 11, 2023
Pharmacokinetic Analysis of Omomyc Shows Lasting Structural Integrity and Long Terminal Half-Life in Tumor TissueMarie-Eve Beaulieu, Sandra Martínez-Martín, Jastrinjan Kaur, et al.
Cancer Research|April 17, 2015
Ibrutinib exerts potent antifibrotic and antitumor activities in mouse models of pancreatic adenocarcinomaDaniel Massó-Vallés, Toni Jauset, Erika Serrano, et al.
Pageof 8